SL-PLUS MIA and SL-PLUS Femoral Stems with Ti/HA

K143096 · Smith & Nephew, Inc. · LZO · Mar 24, 2015 · Orthopedic

Device Facts

• Record ID: K143096
• Device Name: SL-PLUS MIA and SL-PLUS Femoral Stems with Ti/HA
• Applicant: Smith & Nephew, Inc.
• Product Code: LZO · Orthopedic
• Decision Date: Mar 24, 2015
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3353
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The SL-PLUS® MIA Stem and the SL-PLUS® MIA Stem with Ti/HA (INTEGRATION-PLUS®) is indicated for: Indications Standard Stem The SL-PLUS MIA Hip Stem is indicated for individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant. Indications Lateral Stem The SL-PLUS MIA Laterialzed stem is intended for varus femur forms and trumpet shape of the proximal femur (champagne flute) Hip components are also indicated for inflammatory degenerative joint disease including rheumatoid arthritis, arthritis secondary to a variety of diseases and anomalies, and congenital dysplasia; old, remote osteomyelitis with an extended drainage-free period, in which case, the patient should be warned of an above normal danger of infection postoperatively; treatments of nonunion, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; endoprosthesis, femoral osteotomy, or Girdlestone resection; fracture-dislocation of the hip; and correction of deformity. These stems are for uncemented use only. These devices are intended to aid the surgeon in relieving the patient of hip pain and restoring hip motion.

Device Story

Femoral hip prosthesis; uncemented; intended for primary or revision hip arthroplasty. Device consists of forged titanium alloy (Ti-6Al-7Nb) stem with triple-layer coating: two layers of titanium plasma spray and one layer of hydroxyapatite (Ti/HA). Surgeon implants device into femur to replace damaged hip joint; relieves pain; restores motion. Used in clinical/surgical settings. Output is physical structural support for hip joint; aids surgeon in restoring patient mobility. Benefits include relief of hip pain and restoration of joint function.

Clinical Evidence

Bench testing only. Mechanical data indicates the device withstands expected in vivo loading. Surface characterization (physical, chemical, mechanical) of the Ti/HA coating is referenced in Master File MAF-2541.

Technological Characteristics

Materials: Forged titanium alloy (Ti-6Al-7Nb). Coating: Triple-layer (two layers titanium plasma spray, one layer hydroxyapatite) applied by Medicoat AG. Uncemented use only. Standard and lateralized stem geometries available.

Indications for Use

Indicated for patients undergoing primary or revision hip surgery due to trauma, noninflammatory degenerative joint disease (osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, fused hip, pelvic fracture, diastrophic variant), inflammatory degenerative joint disease (rheumatoid arthritis, congenital dysplasia), remote osteomyelitis, nonunion, femoral neck/trochanteric fractures, endoprosthesis, femoral osteotomy, Girdlestone resection, fracture-dislocation, or deformity correction. Lateralized stems indicated for varus femur forms and champagne flute proximal femur shapes. Contraindicated for cemented use.

Regulatory Classification

Identification

A hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis is a device intended to be implanted to replace a hip joint. This device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. The two-part femoral component consists of a femoral stem made of alloys to be fixed in the intramedullary canal of the femur by impaction with or without use of bone cement. The proximal end of the femoral stem is tapered with a surface that ensures positive locking with the spherical ceramic (aluminium oxide, A12 03 ) head of the femoral component. The acetabular component is made of ultra-high molecular weight polyethylene or ultra-high molecular weight polyethylene reinforced with nonporous metal alloys, and used with or without bone cement.

Predicate Devices

• SL-PLUS™ MIA Standard and Lateral Femoral Stems with Ti/HA (K122296)
• SL-PLUS™ Standard and Lateral Femoral Stems with Ti/HA (K120211)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features the department's name in a circular arrangement around a symbol. The symbol is a stylized representation of a human figure, with three faces overlapping to create a sense of depth and connection. The logo is simple, yet recognizable, and represents the department's mission to protect the health of all Americans.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

March 24, 2015

Smith & Nephew, Incorporated Mr. Jeff Sprague Regulatory Affairs Specialist 7135 Goodlett Farms Parkway Cordova, Tennessee 38016

Re: K143096

Trade/Device Name: SL-PLUS™ MIA Femoral Stem with Ti/HA and SL-PLUS™ Femoral Stem with Ti/HA Regulation Number: 21 CFR 888.3353 Regulation Name: Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis Regulatory Class: Class II Product Code: LZO, KWY, LWJ Dated: February 19, 2015 Received: February 20, 2015

Dear Mr. Sprague:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing

{1}------------------------------------------------

(21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

# Lori A. Wiggins -S

for

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# INDICATIONS FOR USE Smith & Nephew SL-PLUS MIA and SL-PLUS Femoral Stem with Ti/HA

# 510(k) Number (if known): K143096

### Device Name: SL-PLUS® MIA Femoral Stem with Ti/HA

### Indications for Use:

The SL-PLUS® MIA Stem and the SL-PLUS® MIA Stem with Ti/HA (INTEGRATION-PLUS®) is indicated for:

### Indications Standard Stem

The SL-PLUS MIA Hip Stem is indicated for individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant.

### Indications Lateral Stem

The SL-PLUS MIA Laterialzed stem is intended for varus femur forms and trumpet shape of the proximal femur (champagne flute)

Hip components are also indicated for inflammatory degenerative joint disease including rheumatoid arthritis, arthritis secondary to a variety of diseases and anomalies, and congenital dysplasia; old, remote osteomyelitis with an extended drainage-free period, in which case, the patient should be warned of an above normal danger of infection postoperatively; treatments of nonunion, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; endoprosthesis, femoral osteotomy, or Girdlestone resection; fracture-dislocation of the hip; and correction of deformity.

These stems are for uncemented use only. These devices are intended to aid the surgeon in relieving the patient of hip pain and restoring hip motion.

Prescription Use x (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

# (PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

{3}------------------------------------------------

# INDICATIONS FOR USE Smith & Nephew SL-PLUS° MIA and SL-PLUS Femoral Stem with Ti/HA

### 510(k) Number (if known): K143096

# Device Name: SL-PLUS® Femoral Stem with Ti/HA

### Indications for Use:

The SL-PLUS® Stem and the SL-PLUS® Stem with Ti/HA (INTEGRATION-PLUS®) is indicated for:

### Indications Standard Stem

The SL-PLUS Stem is intended for advanced hip joint wear due to degenerative, post-traumatic or rheumatoid arthritis; fracture or avascular necrosis of the femoral head

# Indications Lateral Stem

The SL-PLUS Laterialzed stem is intended for varus femur forms and trumpet shape of the proximal femur (champagne flute)

Hip components are also indicated for inflammatory degenerative joint disease including rheumatoid arthritis, arthritis secondary to a variety of diseases and anomalies, and congenital dysplasia; old, remote osteomyelitis with an extended drainage-free period, in which case, the patient should be warned of an above normal danger of infection postoperatively; treatments of nonunion, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; endoprosthesis, femoral osteotomy, or Girdlestone resection; fracture-dislocation of the hip; and correction of deformity.

These stems are for uncemented use only. These devices are intended to aid the surgeon in relieving the patient of hip pain and restoring hip motion.

AND/OR Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 807 Subpart C)

# (PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

{4}------------------------------------------------

# 510(k) Summary Smith & Nephew SL-PLUS™ MIA and SL-PLUS Femoral Stem with Ti/HA

| Submitted by: | Smith & Nephew, Inc.<br>Advanced Surgical Devices Division<br>7135 Goodlett Farms Parkway<br>Cordova, Tennessee 38016 |
|-------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Date of Summary: | October 27, 2014 |
| Contact Person | Jeff Sprague, Regulatory Affairs<br>T [phone] F [phone] |
| Name of Device: | SL-PLUS™ MIA and SL-PLUS Standard and<br>Lateral Femoral Stem with Ti/HA |
| Common Name: | Total Hip Joint, Femoral Component,<br>Cementless |
| Device Classification Name and Reference: | 21 CFR 888.3353 –Hip joint<br>metal/ceramic/polymer semi-constrained<br>cemented or nonporous uncemented<br>prosthesis<br><br>21 CFR 888.3390 – Hip joint femoral (hemi-hip)<br>metal/polymer cemented or uncemented<br>prosthesis<br><br>21 CFR 888.3360 - Hip joint femoral (hemi-hip<br>metallic cemented or uncemented prosthesis |
| Device Class: | Class II |
| Panel Code: | Orthopaedics/87 |
| Product Code: | LZO, KWY, LWJ |

# Device Description

The SL-PLUS® MIA Femoral Stem with Ti/HA coated by Medicoat AG is identical to the coated design of the SL-PLUS™ MIA Femoral Stem cleared via K122296. The subject stems are made from forged titanium alloy, Ti-6AI-7Nb, with a double coating (triple layer): titanium plasma sprayed coating (two layers) with an additional thin layer of hydroxyapatite. The Ti/HA coating form Medicoat AG is substantially equivalent to the Ti/HA coating on the SL-PLUS® MIA Standard and Lateral Femoral Stems with Ti/HA cleared via premarket notification K122296.

The SL-PLUS® Femoral Stem with Ti/HA coated by Medicoat AG is identical to the coated design of the SL-PLUS™ Femoral Stem cleared via K120211. The subject stems are made from forged titanium alloy, Ti-6Al-7Nb, with a double coating (triple layer): titanium plasma sprayed coating (two layers) with an additional thin layer of hydroxyapatite. The Ti/HA coating form Medicoat

{5}------------------------------------------------

AG is substantially equivalent to the Ti/HA coating on the SL-PLUS™ Standard and Lateral Femoral Stems with Ti/HA cleared via premarket notification K120211.

### Intended Use

### SL-PLUS MIA

The SL-PLUS™ MIA Stem and the SL-PLUS™ MIA Stem with Ti/HA (INTEGRATION-PLUS™) is indicated for:

#### Indications Standard Stem

The SL-PLUS MIA Hip Stem is indicated for individuals undergoinq primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant.

#### Indications Lateral Stem

The SL-PLUS MIA Laterialzed stem is intended for varus femur forms and trumpet shape of the proximal femur (champagne flute)

Hip components are also indicated for inflammatory degenerative joint disease including rheumatoid arthritis, arthritis secondary to a variety of diseases and anomalies, and congenital dysplasia; old, remote osteomyelitis with an extended drainage-free period, in which case, the patient should be warned of an above normal danger of infection postoperatively; treatments of nonunion, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; endoprosthesis, femoral osteotomy, or Girdlestone resection; fracture-dislocation of the hip; and correction of deformity.

These stems are for uncemented use only. These devices are intended to aid the surgeon in relieving the patient of hip pain and restoring hip motion.

### SL-PLUS

The SL-PLUS™ Stem and the SL-PLUS™ Stem with Ti/HA (INTEGRATION-PLUS™) is indicated for:

### Indications Standard Stem

The SL-PLUS Stem is intended for advanced hip joint wear due to degenerative, posttraumatic or rheumatoid arthritis; fracture or avascular necrosis of the femoral head

#### Indications Lateral Stem

The SL-PLUS Laterialzed stem is intended for varus femur forms and trumpet shape of the proximal femur (champagne flute)

Hip components are also indicated for inflammatory degenerative joint disease including rheumatoid arthritis, arthritis secondary to a variety of diseases and anomalies, and congenital dysplasia; old, remote osteomyelitis with an extended

{6}------------------------------------------------

drainage-free period, in which case, the patient should be warned of an above normal danger of infection postoperatively; treatments of nonunion, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; endoprosthesis, femoral osteotomy, or Girdlestone resection; fracture-dislocation of the hip; and correction of deformity.

These stems are for uncemented use only. These devices are intended to aid the surgeon in relieving the patient of hip pain and restoring hip motion.

The above indications are substantially equivalent to the indications cleared previously for the SL-PLUS MIA Standard and Lateral Femoral Stem with Ti/HA (K122296) and the SL-PLUS Standard and Lateral Femoral Stem with Ti/HA (K120211).

# Technological Characteristics

A review of the mechanical data indicates that the SL-PLUS™ MIA and SL-PLUS Femoral Stem with Ti/HA is capable of withstanding expected in vivoloading without failure.

# Substantial Equivalence Information

The overall design, materials, and indications for use for the SL-PLUS™ MIA and SL-PLUS Femoral Stem with Ti/HA are substantially equivalent to the following commercially available predicate devices.

| Manufacturer | Description | Submission<br>Number | Clearance<br>Date |
|-----------------------------------|---------------------------------------------------------------|----------------------|-------------------|
| Smith & Nephew<br>Orthopaedics AG | SL-PLUS™ MIA Standard and Lateral Femoral<br>Stems with Ti/HA | K122296 | 9/28/2012 |
| Smith & Nephew<br>Orthopaedics AG | SL-PLUS™ Standard and Lateral Femoral Stems<br>with Ti/HA | K120211 | 7/19/2012 |

The following tests were used as a basis for the determination of substantial equivalence:

- HA powder and coating characterization X
All tests which are in relation to the surface characterization (physical, chemical or mechanical) are discussed in detail in the Ti/HA Coating Master File MAF - 2541 and are not included in this 510(k).

# Conclusion

As previously noted, this 510(k) Premarket Notification is being submitted to request clearance for the SL-PLUS™ MIA Femoral Stem with Ti/HA and SL-PLUS™ Femoral Stem with Ti/HA coated by Medicoat AG. Based on the similarities to the predicate components and a review of the mechanical testing performed, the devices are substantially equivalent to the commercially available predicate devices listed above.